Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 2005Arthritis & Rheumatism

Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT)

View Full Paper
Ask AI
Bookmark
Share

Authors

Désirée van der Heijde
Désirée van der HeijdeRoche (Switzerland)BDBen A. C. DijkmansLeiden UniversityPGPiet GeusensThe University of Sydney

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Heijde et al. (2005) studied this question.

synapsesocial.com/papers/69dbc31d3d9adb00e7684ee6https://doi.org/10.1002/art.20852
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Randomized double‐blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (infliximab) versus placebo in active spondylarthropathy2002 · 353 citations
  2. 2Treatment of Ankylosing Spondylitis by Inhibition of Tumor Necrosis Factor α2002 · 710 citations
  3. 3Evaluation of Diagnostic Criteria for Ankylosing Spondylitis1984 · 5,768 citations
  4. 4HLA-B27 and its subtypes in world populations Editorial review1995 · 236 citations